合肥市生物医药产业现状调查与发展对策研究

Investigation of biological pharmaceutical industry in HeFei: status and perspective

目的调查安徽省合肥市医药产业发展现状,为该市医药产业发展提出对策建议。方法采用典型抽样法抽取安徽医科大学第一附属医院、安徽中医学院第一附属医院、解放军第105医院和安徽省宣城市人民医院2009年至2011年3年药品使用情况,计算安徽省和合肥市生产的药品占合肥市医疗市场品种的构成比以及销售金额构成比;以截止2012年3月通过药品生产许可认证的合肥市药品生产企业为主要研究对象,整群抽样调查企业的工业生产总值和重点产品;采用文献检索和访谈法横向调查对比周边地区医药产业情况,分析安徽省不同发展时期医药产业的布局变化。结果 2009年、2010年和2011年安徽省生产的药品品规分别约占样本医疗机构总品规的20.44%、24.25%和25.08%,其中合肥市生产的品规分别占总品规的0.62%、0.66%和0.81%;安徽省生产的药品消耗金额占总金额的6.19%、7.43%和8.15%,其中合肥市生产的药品占总金额的1.57%、2.50%和3.49%。结论合肥市具有发展生物医药产业的资源优势和一定的产业基础,但赶超先进医药产业企业还有很长的路要走。

Objective To investigate the status of biological pharmaceutical industry in Hefei.Methods We chose the first affiliated hospital of Anhui Medical University,the first affiliated hospital of Anhui university of traditional Chinese medicine,the 105th hospital of PLA and the people＇s hospital of Xuancheng city as the typical sample hospital.This analysis included the data from 2009 to 2011;We obtained the industry gross products and important products of each medical manufacturers in Hefei.Results The medical agents in the four hospitals produced by manufacturers in Anhui province accounted for 20.44%,24.25% and 25.08%,respectively,in 2009,2010 and 2011,of which,produced in Hefei were 0.62%,0.66% and 0.81%,respectively;The total consumption amounts from Anhui province were 6.19%,7.43% and 8.15%,respectively,of which,from Hefei accounted for 1.57%,2.50%and 3.49%,respectively.Conclusion Hefei has the advantages of resources and industrial foundation to develop biological medicine industry.